Syncom Formulations declares ₹0.10 per share dividend at 38th AGM

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Declared a final dividend of ₹0.10 per equity share (10% of face value) for FY26
  • Adopted standalone and consolidated audited financial statements for FY26 with no qualifications
  • Re-appointed Ankit Kedarmal Bankda as Whole-time Director and confirmed Rahul Vijay Bankda as MD
  • Confirmed Rinki Ankit Bankda as Whole-time Director and re-appointed Ruchi Jindal as Independent Director
powered bylight_fuzz_icon
52328969

*this image is generated using AI for illustrative purposes only.

Syncom Formulations (India) Limited declared a final dividend of ₹0.10 per equity share for FY26 during its 38th Annual General Meeting held on September 30, 2026. The payout represents a 10% return on the face value of ₹1 per share.

The meeting, conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM), was chaired by Ankit Kedarmal Bankda. The proceedings were attended by the Board of Directors, statutory auditors from Sanjay Mehta & Associates, and secretarial auditors from D. K. Jain & Co. The quorum was met with 73 members participating through the CDSL platform, exceeding the minimum requirement of 30 members.

Key resolutions passed

Shareholders approved several ordinary and special resolutions, including the adoption of standalone and consolidated audited financial statements for the year ended March 31, 2026. The auditors' report contained no qualifications or negative remarks.

The following key appointments and confirmations were ratified:

  • Re-appointment: Ankit Kedarmal Bankda as Whole-time Director.
  • Confirmation: Rahul Vijay Bankda as Managing Director and Director.
  • Confirmation: Rinki Ankit Bankda as Whole-time Director and Director.
  • Re-appointment: Ruchi Jindal as Woman Independent Director.
  • Remuneration: Approval for increased remuneration for CFO Ankur Vijay Bankda and ratification of Cost Auditor remuneration for FY27.

Governance and compliance updates

The Company Secretary informed members that remote e-voting had commenced on September 27, 2026, and concluded on September 29, 2026. Voting results will be declared within two working days of the meeting's conclusion. The company also noted that unclaimed dividends for seven consecutive years are in the process of being transferred to the Investor Education and Protection Fund (IEPF) Authority.

What the numbers show

The dividend declaration of ₹0.10 per share on 94,00,00,000 equity shares indicates a total payout obligation of approximately ₹9.4 crore. This consistent dividend policy, maintained alongside the clean audit opinion, signals financial stability to shareholders. The high shareholder engagement, with 73 attendees against a minimum of 30, reflects active investor interest despite the virtual format.

Historical Stock Returns for Syncom Formulations

1 Day5 Days1 Month6 Months1 Year5 Years
-4.20%+22.94%+28.88%+129.25%+54.05%+209.63%

How will the increased remuneration for the CFO and the confirmed leadership structure impact Syncom Formulations' operational efficiency and strategic direction in FY27?

What are the implications of the clean audit opinion on the company's ability to secure favorable financing terms or attract institutional investors in the coming fiscal year?

Given the consistent dividend policy, how might Syncom Formulations balance future capital expenditure requirements with maintaining shareholder returns as it scales?

Syncom Formulations promoters waive ₹4.75 crore dividend for FY26

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Promoters waived dividend on 47.53 crore shares held
  • Total dividend waiver amounts to ₹4.75 crore
  • Net dividend payable reduces to ₹4.64 crore
  • Waiver is voluntary and unconditional per SEBI norms
powered bylight_fuzz_icon
51958385

*this image is generated using AI for illustrative purposes only.

Syncom Formulations (India) Limited promoters and promoter group have voluntarily waived their entitlement to the final dividend of ₹0.10 per share proposed for FY26. This decision reduces the total cash outflow by ₹4.75 crore, leaving a net payable amount of ₹4.64 crore for other shareholders.

The waiver applies to 47,53,47,599 equity shares held by the promoter entities, representing approximately 50.5% of the company's total outstanding shares. The Board of Directors had recommended the dividend subject to shareholder approval at the ensuing Annual General Meeting.

Dividend Waiver Details

The company disclosed that the waiver is voluntary, unconditional, and involves no consideration or benefit from the company to the concerned shareholders. The following table outlines the impact on the total dividend payout:

Particulars No. of Equity Shares Amount (₹)
Total Equity Shares 94,00,00,000 -
Final Dividend @ ₹0.10 per Share 94,00,00,000 9,40,00,000
Less: Dividend waived by Promoters (47,53,47,599) (4,75,34,759.90)
Net Final Dividend Payable 46,46,52,401 4,64,65,240.10

What the Numbers Show

Promoters hold exactly 50.57% of the total equity base (47,53,47,599 out of 94,00,00,000 shares). By waiving their share, they effectively reduce the company's immediate liquidity requirement for dividend distribution by more than half. The remaining liability falls entirely on the minority shareholders, who hold 46,46,52,401 shares.

This intimation was filed under Regulation 30 of the SEBI (LODR) Regulations, 2015, and Clause 118 of the Company’s Articles of Association. The final dividend remains subject to declaration by members at the Annual General Meeting.

Historical Stock Returns for Syncom Formulations

1 Day5 Days1 Month6 Months1 Year5 Years
-4.20%+22.94%+28.88%+129.25%+54.05%+209.63%

How will the ₹4.75 crore in retained cash be allocated, specifically regarding capital expenditure or debt reduction plans?

Does this waiver signal a shift in the promoter group's strategy to prioritize long-term growth over immediate shareholder returns?

What impact might this reduced liquidity outflow have on Syncom Formulations' upcoming quarterly financial performance metrics?

More News on Syncom Formulations

Must Read Next

Stocks

Navin Fluorine International to meet analysts and investors on October 12 14 mins ago
no imag found
Aurobindo Pharma subsidiary Acrotech launches AdQuey ointment in US 32 mins ago
Lemon Tree Hotels opens first 65-room Keys Prima in Darjeeling 55 mins ago
1 Year Returns:+54.05%